Susquehanna International Group
ALXA

Susquehanna International Group’s Alexza Pharmaceuticals Inc ALXA Stock Holding History

Susquehanna International Group’s Portfolio ALXA Stock Details ALXA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-26,110
Closed -$13K – 9947
2016
Q1 		$13K Sell
26,110
-10,257
-28% -$4.49K ﹤0.01% 8861
2015
Q4 		$25K Buy
+36,367
New +$37.5K ﹤0.01% 9201
2015
Q1 		– Sell
-35,258
Closed -$72.4K – 10402
2014
Q4 		$53K Buy
35,258
+2,262
+7% +$4.04K ﹤0.01% 9357
2014
Q3 		$77K Buy
+32,996
New +$126K ﹤0.01% 9136
2014
Q2 		– Sell
-14,871
Closed -$64.2K – 10364
2014
Q1 		$66K Sell
14,871
-9,426
-39% -$48.3K ﹤0.01% 8672
2013
Q4 		$115K Buy
+24,297
New +$119K ﹤0.01% 8576

Susquehanna International Group's ALXA Position: Q2 2016 in Review

Susquehanna International Group sold out of Alexza Pharmaceuticals Inc (ALXA) in Q2 2016, closing a stake of 26,110 shares — an estimated $13K sold.

Susquehanna International Group first reported a position in ALXA in Q4 2013 and held it in 6 quarters. The position peaked at $115K in Q4 2013. 0 funds tracked by Wall St. Rank hold ALXA as of Q2 2016.

  • Susquehanna International Group reported no remaining Alexza Pharmaceuticals Inc position as of Q2 2016 after selling out during the quarter.
  • Susquehanna International Group sold 26,110 Alexza Pharmaceuticals Inc shares in Q2 2016, an estimated $13K.
  • Susquehanna International Group first reported a position in Alexza Pharmaceuticals Inc in Q4 2013 and held it in 6 quarters.
  • Susquehanna International Group's Alexza Pharmaceuticals Inc position peaked at $115K in Q4 2013.
  • 0 funds tracked by Wall St. Rank held Alexza Pharmaceuticals Inc as of Q2 2016.

Based on Susquehanna International Group's 13F filing for Q2 2016, filed 15 Aug 2016.